Norris Medicines informs about standalone audited financial results

26 May 2018 Evaluate

Pursuant to Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Norris Medicines has informed about submission of the Standalone Audited Financial Results of the Company for the quarter and Year ended 31st March, 2018; Auditor's Report by Statutory Auditors on Audited Financial Results for the quarter and Year ended 31st March, 2018; and declaration pursuant to Regulation 33 (d) of (Listing Obligation and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Norris Medicines Share Price

13.82 -0.15 (-1.07%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×